
iBio IBIO
€ 1.88
1.85%
Quartalsbericht 2025-Q4
hinzugefügt 10.02.2026
iBio EV 2011-2026 | IBIO
EV Jährlich iBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.3 M | 747 K | 21.7 M | 35.4 M | -39 M | 276 M | 36.8 M | 31.2 M | 46.6 M | 69.7 M | 38.2 M | 21.4 M | 24.6 M | 44.6 M | 87.6 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 276 M | -39 M | 50.4 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
82.6 M | $ 8.48 | 6.0 % | $ 83.8 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.66 | -1.48 % | $ 8.81 B | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Esperion Therapeutics
ESPR
|
1.16 B | $ 2.19 | 0.92 % | $ 455 M | ||
|
Evogene Ltd.
EVGN
|
-4.88 M | $ 0.78 | -4.39 % | $ 27.9 M | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | ||
|
Genmab A/S
GMAB
|
27 B | $ 28.2 | -0.18 % | $ 18 B | ||
|
Grifols, S.A.
GRFS
|
11.8 B | $ 8.38 | 2.01 % | $ 6.83 B | ||
|
GT Biopharma
GTBP
|
-2.9 M | $ 0.38 | 2.47 % | $ 2.1 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 21.28 | 4.44 % | $ 995 M | ||
|
Halozyme Therapeutics
HALO
|
12 B | $ 66.92 | -1.33 % | $ 8.02 B | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 29.05 | 0.55 % | $ 1.67 B | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
Immatics N.V.
IMTX
|
503 M | $ 10.87 | 4.17 % | $ 684 M | ||
|
Incyte Corporation
INCY
|
18.2 B | $ 95.33 | -0.77 % | $ 18.6 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
493 M | $ 1.46 | 4.29 % | $ 375 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
122 M | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 2.99 | 2.4 % | $ 4.92 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
540 M | $ 4.2 | 2.82 % | $ 449 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 24.24 | 0.1 % | $ 3.08 B | ||
|
Innate Pharma S.A.
IPHA
|
259 M | $ 1.47 | 4.26 % | $ 235 M | ||
|
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
2.07 B | $ 32.59 | 1.09 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
11 M | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B |